Articles On Telix Pharmaceuticals (ASX:TLX)
Title | Source | Codes | Date |
---|---|---|---|
TMH Market Update: Unemployment rate drops to 3.6pc in September
Australia’s latest labour force data has dropped and employment remains historically strong with unemployment at 3.6 per cent last month – slightly lower than in August. Another 23,000 people were employed, although the participation rat... |
themarketherald.com.au | TLX | 1 year ago |
Telix Pharmaceuticals share price sinks 12% despite rocketing revenue
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is getting punished today as investors respond to quarterly results and trial findings. In afternoon trade, shares in the radiopharmaceuticals company are positioned 11.7% lower at $9.0... |
Motley Fool | TLX | 1 year ago |
Here's why the Netflix share price just popped 12% overnight
Last night's trading on the United States markets saw something rather incredible happen with the Netflix Inc (NASDAQ: NFLX) share price. It was a tough night for most of the US markets last night (our time). America's Wednesday session sa... |
Motley Fool | TLX | 1 year ago |
Why AMP, Netwealth, Pilbara Minerals, and Telix shares are dropping today
The S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Thursday. In afternoon trade, the benchmark index is down a disappointing 1.3% to 6,986.1 points. Four ASX shares that are falling more than most today are listed below. He... |
Motley Fool | TLX | 1 year ago |
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
Telix Pharma down 17pc despite showing positive Q3 growth metrics Emyria to import MDMA to Australia after approval in Canada Vitura Health and Microba acquired new assets Telix tumbles -17pc Telix Pharma (ASX:TLX) tumbled -17% this mor... |
Stockhead | TLX | 1 year ago |
Why is the Telix share price sinking today?
Telix (ASX:TLX) shareholders are likely today putting their phones down and walking away from the table as the company’s share price tumbles more than 15 per cent in early afternoon trade The stock dove below the line in tandem with the... |
themarketherald.com.au | TLX | 1 year ago |
5 things to watch on the ASX 200 on Thursday
On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was on form again and recorded a decent gain. The benchmark rose 0.3% to 7,077.6 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200 expe... |
Motley Fool | TLX | 1 year ago |
Telix reports fourth consecutive quarter of positive operating cash flow
MELBOURNE, Australia, Oct. 18, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 September... |
FNArena | TLX | 1 year ago |
ASX passive income of $200 a week? See how you can do it for $5 per day
A passive income of $200 each week for the rest of your life would be pretty handy for most Australians, but it's not such an outlandish dream. In fact, it's very achievable if you can commit to chipping in just $5 each day. That's the pri... |
Motley Fool | TLX | 1 year ago |
HRH Princess Astrid of Belgium visits Telix’s New European Manufacturing Facility in Brussels South
MELBOURNE, Australia and LIEGE, Belgium, Sept. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) has welcomed Her Royal Highness, Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (T... |
FNArena | TLX | 1 year ago |
20% a year? 3 ASX growth shares that doubled in 4 years
If you're already reading The Motley Fool, then you already have some idea that ASX growth shares are capable of bringing extraordinary riches. But there's nothing like cold hard numbers to demonstrate that power. How would you feel about... |
Motley Fool | TLX | 1 year ago |
“Your Stock Request” – 21 September 2023
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | TLX | 1 year ago |
Who wants to be a millionaire? 3 ASX shares I think that could make it happen
Fancy having a million dollars to your name? Even though there is only a $5 difference between having $999,995 and having a seven-figure amount in your bank account, there is something about the title of "a millionaire" that continues to f... |
Motley Fool | TLX | 1 year ago |
Who wants to be a millionaire? 3 ASX shares I think could make it happen
Fancy having a million dollars to your name? Even though there is only a $5 difference between having $999,995 and having a seven-figure amount in your bank account, there is something about the title of "a millionaire" that continues to f... |
Motley Fool | TLX | 1 year ago |
ASX cancer stocks guide: Here’s everything you need to know
According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W... |
Stockhead | TLX | 1 year ago |
Dr Boreham’s Crucible: The path to a US$10bn market by 2026 is clear for Claritylarity
The radiopharmaceuticals outfit’s market valuation has been irradiated since it raised a record $92 million and listed just over two years ago. Meanwhile, its bigger and wildly successful peer Telix Pharmaceuticals hogs the investor limelig... |
Stockhead | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
It's been a happy end to the trading week indeed for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Friday. After having a fairly bumpy week, the ASX 200 went out in style today, recordi... |
Motley Fool | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) had another shaky day on Tuesday. Yesterday seemed to show that investors couldn't decide what they wanted out of the markets, with stints on both positive and ne... |
Motley Fool | TLX | 1 year ago |
Brokers name 3 ASX shares to buy now
It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these... |
Motley Fool | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
It's been another horrid day for the S&P/ASX 200 Index (ASX: XJO) in a selloff trend that seems to be accelerating this week. Today's falls are the third day of drops in a row for the ASX 200 after... |
Motley Fool | TLX | 1 year ago |
ASX Large Caps: Shares slump over 1pc as Qantas sells down some more; Albo’s off to China
Local shares slumped by more than 1.1pc today All 11 sectors were down, led by BHP and Allkem Phil Lowe made his final speech as RBA governor The ASX slipped further on Thursday, down by -1.2% as the index tracked its worst day in three... |
Stockhead | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) seems to be starting a run of bad news for ASX investors. After yesterday’s mild fall, the ASX 200 took a deeper dive into negative territory today. By close of tradi... |
Motley Fool | TLX | 1 year ago |
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM
MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the 36th Annual Congress of the European Associ... |
FNArena | TLX | 1 year ago |
Rudi’s View: Outlook Negative, With Plenty Of Silver Linings
In this week's Weekly Insights:-Outlook Negative, With Plenty Of Silver Linings-Conviction Calls & Best IdeasBy Rudi Filapek-Vandyck, EditorOne of the stand-out features of the August results season has been the resilience of household ... |
FNArena | TLX | 1 year ago |
3 ASX shares for sustainable investment returns
Damian Cottier dives into why and how ASX investors can use ESG principles to their advantage, and offers up three examples in Telix Pharmaceuticals (ASX: TLX), Alpha HPA Ltd (ASX: A4n) and Calix Ltd (ASX: CXL). Now more than ever we need t... |
Rask Media | TLX | 1 year ago |
FNArena Corporate Results Monitor – 28-08-2023
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ABB)) - Aussie Broadband ((AFG)) - Australian Finance Group ((AVG)) - Australian Vintage ((BVS)) - Bravura Solutions ((CBO)) - Cobram Estate Oli... |
FNArena | TLX | 1 year ago |
How to turn a $20k ASX share portfolio into $15,000 yearly second income
Do you have $20,000 saved that you could invest in ASX shares? If so, I reckon you could turn it into a portfolio that pays you an extra income of $15,000 each year. It’s like having a second job, but without the work. Let’s take a look at... |
Motley Fool | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) has ended its three-day winning streak with a disappointing finish to the trading week today. At the conclusion of today’s session, the ASX 200 had recorded a notable drop... |
Motley Fool | TLX | 1 year ago |
Why Core Lithium, Northern Star, Tabcorp, and Telix shares are storming higher
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At the time of writing, the benchmark index is up 0.45% to 7,181.6 points. Four ASX shares that are rising more than most today are listed belo... |
Motley Fool | TLX | 1 year ago |
4 ASX healthcare shares charging higher on positive earnings updates
These four ASX healthcare shares are bucking the trend today with strong share price gains following the release of their latest financial reports. As earnings season continues, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down 0.0... |
Motley Fool | TLX | 1 year ago |
ASX 200 healthcare stock Telix Pharmaceuticals surges 12% on ‘excellent result’
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a strong session. At the time of writing, the ASX 200 healthcare stock is up almost 12% to $10.94. This follows the release of the companyâs half-year results. Telix share pr... |
Motley Fool | TLX | 1 year ago |
Telix says result reflects its transition to a sustainable commercial-stage company
Telix (ASX:TLX) has reported total revenue of $220.8 million for the six months to the end of June 2023, driven by growth in prostate cancer imagined agent Illuccix. |
BiotechDispatch | TLX | 1 year ago |
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
MELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended 30 June 2023. All figures are in AUD$ unless otherwise stated.[... |
FNArena | TLX | 1 year ago |
If I’d invested $2,400 in this ASX 200 stock 20 years ago I’d have $1 million today!
Buying any S&P/ASX 200 Index (ASX: XJO) stock undoubtedly comes with risks. But if you pick the right one and hold it for a long time, extraordinary riches can come about. Even though the Australian bourse is famous for its dividend st... |
Motley Fool | TLX | 1 year ago |
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
MELBOURNE, Australia, Aug. 11, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in China in the pivotal Phase III registration study of TLX591-CDx (Illuc... |
FNArena | TLX | 1 year ago |
Telix Pharmaceuticals (ASX:TLX) initiates first patient dosing in phase III prostate cancer imaging study in China
Telix Pharmaceuticals (TLX) doses its first Chinese patient in the phase III study of TLX591-CDx (Illuccix) with Grand Pharmaceutical Group Illuccix is employed for positron emission tomography (PET) imaging of prostate cancer The Chi... |
themarketherald.com.au | TLX | 1 year ago |
First Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed Glioblastoma
MELBOURNE, Australia, Aug. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase I study of the Company’s investigational therapy TLX101 (4-L-[1... |
FNArena | TLX | 1 year ago |
MoneyTalks: How and where to spot multibaggers, and a couple of fundie’s recommendations
How do you spot multibagger stocks? Which sectors can you find them in, and which ASX stocks have good potential? Stockhead reached out to VP Capital’s co-founder, John So As the name suggests, multibaggers are stocks that can generate... |
Stockhead | TLX | 1 year ago |
China kicks the semiconductor chip war up a notch as gallium and germanium restrictions come in to play
China’s export controls on gallium and germanium come into effect today with licensing procedures with provincial governments now required to export them freely. Both metals are critical components in semiconductor chips, the building block... |
Stockhead | TLX | 1 year ago |
Dr Boreham’s Crucible: Telix Pharmaceuticals
Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports. By Tim Boreham ASX Code: ((TLX)) Share price: $11.26 Shares on issue: 318,808,268 Market cap: $3.58 billion Chief executive officer: Dr Christian Behr... |
FNArena | TLX | 1 year ago |
Stayer’s secrets: Mercer’s top fundie
Australian Eagle Asset Management is the top performing fund manager over a five-year period with their Equity Strategy Fund delivering an impressive return of 11.6 per cent per annum, compared to the ASX 100 Accumulation Index which return... |
Montgomery | TLX | 1 year ago |
Rudi’s View: ARB, Corporate Travel, Goodman Group, NextDC, Orora, Worley & Xero
In this week's Weekly Insights:-Opportunities With A Five Year Horizon-Company Reports: Early Trends-Company Reports: Inflation-Company Reports: Conviction-Company Reports: Technology Sector-REITs In FocusBy Rudi Filapek-Vandyck, Editor FNA... |
FNArena | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) has suffered a disappointing start to the trading week this Monday. After initially rising with enthusiasm, the ASX 200 spent most of the trading session running out of steam. By market close, the... |
Motley Fool | TLX | 1 year ago |
Closing Bell: ASX 200 ends in damp squib on flat day; Core Lithium tumbles as Telix recovers
The ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks carried the torch with enthusiasm, while Materials wasn’t let anywhere near said torch Notable performers today: pharma stock Telix (ASX:TLX... |
Stockhead | TLX | 1 year ago |
ASX Large Caps: Shares flat after strong jobs data and updates from miners; Telix tumbles 15pc on Q2 results
Shares closed flattish as Aussie jobless rate falls to 3.5% Earnings season heats up as a handful of miners give updates China keeps cash rate unchanged, dashing market hopes Local shares closed flat on Thursday as traders assessed the... |
Stockhead | TLX | 1 year ago |
Why Brainchip, Impedimed, Northern Star, and Telix shares are falling today
The S&P/ASX 200 Index (ASX: XJO) is on form again and on track to record a small gain. In afternoon trade, the benchmark index is up 0.2% to 7,340 points. Four ASX shares that have failed to follow the market higher today are listed... |
Motley Fool | TLX | 1 year ago |
Why is the Telix share price crashing 17% today?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price has come under pressure on Thursday. In morning trade, the radiopharmaceutical companyâs shares are down 17% to $10.06. Why is the Telix share price crashing? Investors have been selli... |
Motley Fool | TLX | 1 year ago |
The Overnight Report: Awaiting Results
World Overnight SPI Overnight 7286.00 + 2.00 0.03% S&P ASX 200 7323.70 + 39.90 0.55% S&P500 4565.72 + 10.74 0.24% Nasdaq Comp 14358.02 + 4.38 0.03% DJIA 35061.21 + 109.28 0.31% S&P500 VIX 13.76 + 0.46 3.46% US 10... |
FNArena | TLX | 1 year ago |
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow
MELBOURNE, Australia, July 19, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 June 2023... |
FNArena | TLX | 1 year ago |
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib
MELBOURNE, Australia, July 19, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation... |
FNArena | TLX | 1 year ago |